Form 8-K - Current report:
SEC Accession No. 0001193125-26-224161
Filing Date
2026-05-14
Accepted
2026-05-14 16:29:55
Documents
13
Period of Report
2026-05-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d110930d8k.htm   iXBRL 8-K 29577
2 EX-99.1 d110930dex991.htm EX-99.1 13197
6 GRAPHIC g110930g0514215127714.jpg GRAPHIC 5301
  Complete submission text file 0001193125-26-224161.txt   172055

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20260514.xsd EX-101.SCH 3183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20260514_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20260514_pre.xml EX-101.PRE 11263
16 EXTRACTED XBRL INSTANCE DOCUMENT d110930d8k_htm.xml XML 3629
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 883099146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 26979530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)